By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Formatech, Inc. 

200 Bulfinch Drive

Andover  Massachusetts  01810  U.S.A.
Phone: 978-725-9077 Fax: 978-725-9078

Formatech, Inc. is a contract development services company and aseptic clinical supply manufacturer. Formatech's experience encompasses biotherapeutics and synthetically derived pharmaceuticals in all stages of the product development process. Formatech, Inc. serves biotechnology and pharmaceutical companies ranging in size from virtual to fully integrated. The company philosophy dictates that individual problems demand individual solutions. "We formulate solutions‚" embodies Formatech's proven ability to formulate need-specific solutions to complex product development, characterization and manufacturing issues.

Key Services

  • Product Development Services

    • Pre-formulation development
    • Formulation development
    • Dosage form development
    • Cell culture (E. coli and CHO)
    • Biopharmaceutical purification/process development
    • Stability FingerPrintingTM
    • Lyophilization development

  • Clinical Supply Manufacturing Services

    • Aseptic filling of liquid clinical batches
    • Production of lyophilized clinical batches
    • Fully validated Class 100 environment
    • Technology transfer of final product manufacture


  • Product Development
    Lynne Bartkowski, Director-Marketing and Sales

  • Clinical Supply Manufacturing
    Jennifer Willis, Manufacturing Sales Specialist

    Last Updated 8-28--01

    Key Statistics

    Ownership: Private

    Web Site: Formatech, Inc.

  • Industry

    Company News
    Formatech, Inc. to Donate Services to Formulate and Fill Femta Pharmaceuticals’ FM101 Monoclonal Antibody under Its "Fillanthropy(TM) Program" 7/30/2010 11:26:28 AM
    Formatech, Inc. Donates Manufacturing Services to RegeneRx Biopharmaceuticals, Inc. (RGRX) to Produce Experimental Drug for the Treatment of Multiple Sclerosis 4/30/2010 9:08:03 AM
    Cellceutix Signs Agreement for Kevetrin(TM) Formulation With Formatech, Inc. 3/22/2010 11:05:32 AM
    Formatech, Inc. Donates Services to Formulate and Fill TRACON Pharmaceuticals, Inc.'s TRC102 Compound under Its "Fillanthropy(TM) Program" 3/22/2010 9:16:32 AM
    USPTO Grants Formatech Novel Drug Formulation Patent 2/12/2010 9:39:11 AM
    Formatech, Inc. Donates over $300K in Manufacturing Services Through "Fillanthropy Program" 1/29/2010 9:53:54 AM
    Formatech, Inc. Donates over $300K in Manufactuing Services Through "Fillanthropy Program" 1/28/2010 9:13:25 AM
    Formatech, Inc.'s "Fillanthropy Program" Donates Services to Formulate and Fill ViroMed's VM206 Vaccine Targeting Breast Cancer 1/5/2010 9:40:51 AM
    Formatech, Inc. Release: The New Face of 11/20/2009 8:34:28 AM
    Formatech, Inc. to Donate Services to Manufacture KAI Pharmaceuticals, Inc.'s Clinical Candidate Under Its "Fillanthropy(TM) Program" 11/18/2009 9:35:04 AM